Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2021-11-30 00:00:00 ET · period of report 2021-11-26 · accession 0001209191-21-067149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-30 | 2021-11-26 | VIR | SATO VICKI L | Dir | S - Sale | $36.80 | -15.2K | 1.57M | -1.0% | -$558.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-26 | S | D | 15,174 | $36.80 | 1,566,266 | D | — | — |